![(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-((S)-(E)-3-hydroxyoct-1-enyl)-cyclopentyl]hept-5-enoic acid,CAS No. 551-11-1.](https://public.whmall.com/system/0/chemical/image/2007/09/04/1188888888-2201903_C20H34O5.png "(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-((S)-(E)-3-hydroxyoct-1-enyl)-cyclopentyl]hept-5-enoic acid,CAS No. 551-11-1.")
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-((S)-(E)-3-hydroxyoct-1-enyl)-cyclopentyl]hept-5-enoic acid CAS No.551-11-1 / Cat No.EBD2201903
Prostalmon F
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-((S)-(E)-3-hydroxyoct-1-enyl)-cyclopentyl]hept-5-enoic acid
dinoprost
prostaglandin F2-alpha
Prostaglandin F2A
9,11,15-trihydroxyprosta-5,13-dien-1-oicacid
amoglandin
cyclosin
dinolytic
enzaprost
enzaprostf
glandin
9,11,15-trihydroxyprosta-5,13-dien-1-oic acid
(9alpha,11alpha,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid
Properties
-
Appearance:
White to off-white crystalline solid
-
Density:
1.153 g/cm3
-
Boiling point:
531 °C at 760 mmHg
-
Flashing point:
289 °C
NMR Spectrum
Prediction： 1H NMR (400 MHz; CDCl3) deltaEta = 0.89 (3 H, t, J = 6.8 Hz, CH3), 1.24-1.41 (6 H, m, 3 x CH2), 1.43-1.54 (2 H, m,), 1.54-1.63 (1 H, m), 1.63-1.73 (2 H, m), 1.76 (1 H, m), 2.07-2.28 (5 H, m), 2.28-2.39 (3 H, m), 3.96 (1 H, m, CAOH), 4.11 (1 H, q, J = 6.8 Hz, CAOH), 4.18 (1 H, m, CAOH), 4.35-5.20 (1 H, br. s, C02H), 5.32-5.41 (1 H, m, =CH), 5.41-5.50 (1 H, m, =CH), 5.50 (1 H, dd, J = 15.4, 8.4 Hz, =CH), 5.58 (1 H, dd, J = 15.4, 6.6 Hz, =CH)
1H NMR
13C NMR
